Clinical Trial

Comparison of Transcutaneous and Arterial Carbon Dioxide Sampling During Jet Ventilation, a Prospective. Study on Patients Undergoing Percutaneous Liver Tumour Radiofrequency Ablation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 8, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The study aims to compare the readings from two methods of monitoring carbon dioxide levels during jet ventilation when normal end-tidal monitoring is not possible. During jet ventilation it is technically not possible to monitor the levels of carbon dioxide in exhaled air as is the standard in preoperative care. We will compare transcutaneous (through the skin) monitoring to an arterial blood. sample. Both transcutaneous monitoring and arterial monitoring is currently used as the standard for this patient group at our institution. By collecting data prospectively we can evaluate if there. are discrepancies based on monitoring method. All patients will be treated per standard preoperative protocol and only patients consenting to participate will contribute data to the comparison and statistical analysis.
Trial Details
NCT Number NCT07211763
Lead Sponsor Sahlgrenska University Hospital
Conditions Liver Ablation, High Frequency Jet Ventilation
Enrollment 100 participants
Start Date 2025-04-01
Primary Completion 2026-06 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-10-08